$114.23
1.811.61%
At close: -
$114.23
0.000.00%
After Hours: Dec 20, 4:34 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Abbott Laboratories (ABT) was reported on October 16, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $1.31 to $1.37, compared to the estimated EPS of $1.34. Additionally, Abbott Laboratories forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.